Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
54.62
+0.21 (0.39%)
Nov 20, 2024, 4:00 PM EST - Market open

Agios Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
3,1151,2451,5431,7853,0013,265
Upgrade
Market Cap Growth
83.23%-19.32%-13.57%-40.52%-8.08%21.70%
Upgrade
Enterprise Value
1,5154486074882,6442,840
Upgrade
Last Close Price
54.6222.2728.0832.8743.3347.75
Upgrade
PE Ratio
4.63--1.24--
Upgrade
PS Ratio
93.9146.40108.35---
Upgrade
PB Ratio
1.911.531.401.387.515.10
Upgrade
P/TBV Ratio
1.551.531.401.387.515.10
Upgrade
EV/Sales Ratio
46.0916.6942.61---
Upgrade
Debt / Equity Ratio
0.040.090.080.080.260.18
Upgrade
Asset Turnover
0.020.020.01---
Upgrade
Inventory Turnover
13.7021.65----
Upgrade
Quick Ratio
8.4411.4912.5417.176.076.25
Upgrade
Current Ratio
8.9912.2713.3017.796.746.59
Upgrade
Return on Equity (ROE)
53.65%-36.83%-19.37%-42.15%-63.33%-45.39%
Upgrade
Return on Assets (ROA)
-18.17%-22.49%-18.17%-20.65%-24.08%-22.60%
Upgrade
Return on Capital (ROIC)
-19.20%-23.65%-18.88%-24.98%-33.35%-27.42%
Upgrade
Earnings Yield
21.65%-28.29%-15.02%89.89%-10.91%-12.60%
Upgrade
FCF Yield
-10.60%-23.87%-20.38%-23.14%-10.16%-11.72%
Upgrade
Buyback Yield / Dilution
-3.17%-1.57%9.36%12.39%-15.01%-4.49%
Upgrade
Total Shareholder Return
-3.17%-1.57%9.36%12.39%-15.01%-4.49%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.